Potassium

Written for veterinarians and veterinary nurses.Are you a pet owner? The owner guides are here.

This page reprints a manufacturer label. Everything below in quotation marks is copied from RenaKare Gel, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.

This page reprints the FDA label for RenaKare Gel by Neogen Corporation-Mercer Rd, a potassium product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 3 other stored labels carry the same active ingredient and are listed at the end.

The label

Product: RenaKare Gel. Manufacturer: Neogen Corporation-Mercer Rd. FDA Structured Product Label set id 4550c672-8c64-4eae-87a7-e9812904b2f7. Label effective 2024-01-23. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.

Indications

For use as a potassium supplement in hypokalemic cats and dogs.

Dosage and Administration

Adult cats and dogs.....2 mEq/4.5 kg (½ tsp/10 lb) PO BID Kittens and puppies............Consult veterinarian Administer with food. Gel is highly palatable. Place small amount on animal’s nose or in mouth to initiate interest. Place gel on food or on animal’s paw thereafter. Dosage may be adjusted as necessary by the veterinarian. Store in a dry place at a temperature between 15°-30°C (59°-86°F). Keep container tightly closed. UPC 7 26087 09076 4 ​KEEP OUT OF REACH OF CHILDREN

Warnings

Do no administer in diseases where high potassium levels may be encountered, such as severe renal insufficiency or adrenal insufficiency.

Precautions

Use with caution in the presence of cardiac disease, particularly in digitalized patients or in the presence of renal disease. Manufactured for Neogen Corporation Lexington, KY 40511 859-254-1221 neogen.com PRINCIPAL DISPLAY PANEL - 5 oz Bottle NDC: 59051-9076-6 RenaKare™ Gel Potassium Gluconate CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. NEOGEN® Vet Net Contents: 5 oz (142 g) RenaKare Gel 5oz (142 g)

Other labels for this ingredient

These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.

FDA adverse event reports

The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming potassium as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.

These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.

Dogs: 3,412 reports

Reactions most often coded in dogs, 3,412 reports
VeDDRA reaction termReports
Vomiting692
Lethargy (see also Central nervous system depression in 'Neurological')520
Lack of efficacy - NOS449
Other abnormal test result NOS340
Anorexia305
Death by euthanasia300
Diarrhoea290
Elevated alanine aminotransferase (ALT)260
Seizure NOS251
Emesis224
Death221
Leucocytosis NOS214
Decreased appetite210
Not eating206
Elevated serum alkaline phosphatase (SAP)193

Outcome as recorded by the reporter: Ongoing 1,345; Recovered/Normal 800; Outcome Unknown 699; Euthanized 299; Died 236; Recovered with Sequela 35.

Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.

Cats: 1,336 reports

Reactions most often coded in cats, 1,336 reports
VeDDRA reaction termReports
Vomiting294
Lethargy (see also Central nervous system depression in 'Neurological')169
Lack of efficacy - NOS147
Diarrhoea145
Anorexia144
Death by euthanasia125
Death118
Weight loss116
Not eating104
Other abnormal test result NOS94
Decreased appetite84
Lethargy (see also Central nervous system depression in Neurological)84
Ataxia81
Dehydration80
Lack of efficacy (bacteria) - NOS80

Outcome as recorded by the reporter: Ongoing 464; Outcome Unknown 348; Recovered/Normal 265; Died 126; Euthanized 125; Recovered with Sequela 7.

Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.

Sources

Related

From Glarda

The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.

Glarda for practices